Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
Dominic G. Rothwell,Mahmood Ayub,Natalie Cook,Fiona Thistlethwaite,Louise Carter,Emma Dean,Nigel Smith,Shaun Villa,Joanne Dransfield,Alexandra Clipson,Daniel White,Kamrun Nessa,Saba Ferdous,Matthew Howell,Avinash Gupta,Bedirhan Kilerci,Sumitra Mohan,Kris Frese,Sakshi Gulati,Crispin Miller,Allan Jordan, Helen Eaton,Nicholas Hickson,Ciara O’Brien,Donna Graham,Claire Kelly,Sreeja Aruketty,Robert Metcalf,Jaseela Chiramel,Nadina Tinsley,Alexander J. Vickers,Roopa Kurup,Hannah Frost,Julie Stevenson,Siobhan Southam,Dónal Landers,Andrew Wallace,Richard Marais,Andrew M. Hughes,Ged Brady,Caroline Dive,Matthew G. Krebs NATURE MEDICINE（2019）
Key words
ctdna,clinical trials,patient selection
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper